Luft et al used the Endothelial Activation and Stress Index (EASIX) to evaluate patients with graft-versus-host disease after allogeneic stem-cell transplants. The authors are from University Hospital Heidelberg, German Cancer Research Center, Cincinnati Children's Hospital, University of Washington and Charite University Medicine Berlin.